Clinical Trial Update: A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit [Phase 1]

View source ↗

Summary

Phase 1 study evaluating NN3201, a c-Kit targeted antibody-drug conjugate, in advanced and/or metastatic solid tumors expressing c-Kit; currently recruiting acr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma
• Chromophobe Renal Cell Carcinoma
• Clear Cell Renal Cell Carcinoma
• Gastrointestinal Stromal Tumor
• Neuroendocrine Tumor
• Small Cell Lung Cancer
• Uveal Melanoma

Drugs mentioned

• NN3201 (NN3201)

Snippet

Sponsor: Novelty Nobility, Inc. | Conditions: Gastrointestinal Stromal Tumors, Small-cell Lung Cancer | Phase 1 | Status: RECRUITING